# Fortrea

Organization · id `cardio:org-fortrea` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Fortrea>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 4 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Fortrea
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation (`cardio:ct-nct04702451`)
- Sponsors: A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure (`cardio:ct-nct06692764`)
- Sponsors: A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China (`cardio:ct-nct06933472`)
- Sponsors: Vortosiran for VTE Prevention (`cardio:ct-nct07850453`)

## Provenance

Content hash: bf682e3a9c797f6ae051f1b1314c2c80cb6ce51f09e5c55346afb31fe8940223
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
